EW vs SON · P/E 47, rev $1.39B vs P/E 57, rev $1.36B
Edwards Lifesciences Corp (EW) versus Sonoco Products Company (SON) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Sonoco Products Company (SON) is a packaging & containers company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SON revenue for 2024-12-31 was $1.36B. Net income was $163.9M. Revenue was up 0.6% from 2024-09-29 to 2024-12-31. SON currently screens at market cap $4.59B and trailing P/E 56.7.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SON currently screens at market cap $4.59B and trailing P/E 56.7.
Not investment advice. Open the EW and SON stock pages for the full models.
Not investment advice.